ExpertiseUpdated on 27 April 2026
Swine and Minipig Preclinical Expertise for Translational Drug Development
About
Athens LifeTech Park (ALTP) offers specialist preclinical services built around swine and minipig models — one of the most physiologically relevant large animal platforms for translational drug development. Swine share significant anatomical, physiological, and genomic similarities with humans, making them particularly valuable for cardiovascular, dermatological, metabolic, and surgical device studies, as well as DMPK and early toxicology work.
ALTP's team brings deep expertise in study design, animal handling, and data interpretation, with scientists genuinely engaged with each program rather than operating as a transactional service provider. Our facility is purpose-built for preclinical and early clinical research, operating within full EU regulatory standards in one of Europe's most cost-competitive environments.
We are actively seeking collaborations with pharma companies, biotechs, and MedTech developers looking for a credible, experienced large animal CRO partner in Europe. If your pipeline includes programs where swine models could accelerate your translational path, we would be glad to connect.
Organisation
Similar opportunities
Partnership
Early-Stage Drug Development Partnerships in Europe's Most Cost-Competitive Environment
Angeliki Velentza Almpani
Scientific Business Development Lead at Athens LifeTech Park
Athens, Greece
Partnership
Strategic partnerships for vascularized 3D tumour models in preclinical oncology
Karolina Valente
CEO at VoxCell BioInnovation
Victoria, Canada
Expertise
- Biotech, Pharma and Cosmetics
Subhadra Dravida
Founder CEO at Transcell Biologics
Hyderabad, India